Cargando…
Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526220/ https://www.ncbi.nlm.nih.gov/pubmed/23264295 http://dx.doi.org/10.2337/dc12-1218 |
| _version_ | 1782253521937104896 |
|---|---|
| author | DeVries, J. Hans |
| author_facet | DeVries, J. Hans |
| author_sort | DeVries, J. Hans |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3526220 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35262202014-01-01 Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 DeVries, J. Hans Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-01 2012-12-11 /pmc/articles/PMC3526220/ /pubmed/23264295 http://dx.doi.org/10.2337/dc12-1218 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses DeVries, J. Hans Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
| title | Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
| title_full | Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
| title_fullStr | Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
| title_full_unstemmed | Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
| title_short | Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 |
| title_sort | comment on: rizzo et al. reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-iv inhibition. diabetes care 2012;35:2076–2082 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526220/ https://www.ncbi.nlm.nih.gov/pubmed/23264295 http://dx.doi.org/10.2337/dc12-1218 |
| work_keys_str_mv | AT devriesjhans commentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082 |